Table 5.
Experimental treatments | ALP1 (U/L) |
AST2 (U/L) |
ALT3 (U/L) |
GGT4 (U/L) |
---|---|---|---|---|
Control | 203.41c | 221.25b | 6.65b | 10.22b |
Silymarin | 225.18b | 225.91b | 7.28ab | 10.85b |
CCl4 | 262.28a | 236.56a | 8.39a | 12.61a |
Silymarin × CCl4 | 232.65b | 227.03ab | 8.15a | 11.46ab |
SEM | 14.19 | 2.44 | 0.34 | 0.41 |
a-c means within a column with different superscript differ significantly (P<0.05).
1ALP, Alkaline phosphatase; 2AST, Aspartate aminotransferase; 3ALT, Alanine aminotransferease; 4GGT, Gamma-glutamyl transferase.